NCT07284030

Brief Summary

This randomized controlled trial evaluates the effectiveness of a web-based psychoeducation program on psychological well-being and quality of life in breast cancer survivors who completed active treatment at least one year earlier. Seventy-two women will be randomly assigned to either a 6-week online psychoeducation program plus standard care or standard care alone. The intervention consists of weekly 30-45 minute online sessions focusing on coping strategies, psychosocial adjustment, quality of life, and psychological well-being. Primary outcomes include psychological well-being, fear of cancer recurrence, quality of life, and hopelessness, assessed at baseline, post-intervention, and 2-month follow-up.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
72

participants targeted

Target at P25-P50 for not_applicable breast-cancer

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2025

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

December 1, 2025

Completed
14 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2025

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 16, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

December 16, 2025

Status Verified

December 1, 2025

Enrollment Period

8 months

First QC Date

December 1, 2025

Last Update Submit

December 14, 2025

Conditions

Keywords

Breast cancerPsychoeducationWeb-based intervention

Outcome Measures

Primary Outcomes (2)

  • Change in Psychological Well-Being

    Measured by the Psychological Well-Being Scale Change in psychological well-being measured using the Psychological Well-Being Scale. The scale consists of 8 items rated on a 7-point Likert scale, with total scores ranging from 8 to 56. Higher scores indicate better psychological well-being.

    Baseline, 6 weeks (post-intervention), and 2-month follow-up

  • Change in Fear of Cancer Recurrence

    Measured by the Fear of Cancer Recurrence Inventory Change in fear of cancer recurrence measured using the Fear of Cancer Recurrence Inventory. Items are scored on a 5-point Likert scale (0-4), with higher scores indicating greater fear of cancer recurrence.

    Baseline, 6 weeks (post-intervention), and 2-month follow-up

Secondary Outcomes (3)

  • Change in Cancer-Related Quality of Life

    Baseline, 6 weeks, and 2-month follow-up

  • Change in Hopelessness

    Baseline, 6 weeks, and 2-month follow-up

  • Change in Breast Cancer-Specific Quality of Life

    Baseline, 6 weeks, and 2-month follow-up

Study Arms (2)

Intervention Group

EXPERIMENTAL

Participants receive a 6-week web-based psychoeducation program plus standard care

Behavioral: Web-Based Psychoeducation Program

Control Group

NO INTERVENTION

Participants receive standard care only

Interventions

Six-week structured psychoeducation program delivered online through www.onkodestek.org website and weekly Zoom sessions. Topics include living with breast cancer, managing psychosocial issues, improving quality of life, psychological well-being, and finding hope and meaning. Each session lasts 30-45 minutes.

Intervention Group

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female breast cancer survivors
  • Completed active breast cancer treatment (surgery, chemotherapy, radiotherapy) at least 12 months ago
  • Currently in remission (no evidence of active disease)
  • Age between 18-65 years
  • Able to read and write Turkish
  • Access to computer or smartphone with internet connection
  • Able to participate in online video sessions via Zoom
  • Willing to provide informed consent

You may not qualify if:

  • Current cancer recurrence or metastatic disease
  • Active psychiatric disorder requiring treatment
  • Cognitive impairment that prevents participation in online sessions
  • Currently receiving active cancer treatment (excluding hormonal therapy)
  • Participation in another psychosocial intervention study
  • No internet access or inability to use web-based platforms
  • Male breast cancer patients
  • Unable to commit to 6-week program schedule

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Breast Cancer Outpatient Clinic

Istanbul, 34740, Turkey (Türkiye)

RECRUITING

Related Publications (2)

  • Karsten MM, Roehle R, Albers S, Pross T, Hage AM, Weiler K, Fischer F, Rose M, Kuhn F, Blohmer JU. Real-world reference scores for EORTC QLQ-C30 and EORTC QLQ-BR23 in early breast cancer patients. Eur J Cancer. 2022 Mar;163:128-139. doi: 10.1016/j.ejca.2021.12.020. Epub 2022 Jan 20.

    PMID: 35066338BACKGROUND
  • Mateu P, Teixidor-Batlle C, Suarez-Alcazar MP, Salas-Medina P, Catala-Vilaplana I, Hernando-Domingo C, Muriach M, Collado-Boira E. A qualitative case study of body image in women with breast cancer participating in an exercise program. Support Care Cancer. 2025 Oct 1;33(10):893. doi: 10.1007/s00520-025-09963-z.

    PMID: 41032141BACKGROUND

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Central Study Contacts

Yasemin Nazlı, Clinical Nurse Specialist

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
This is an open-label study where masking is not feasible due to the nature of the intervention. Participants in the intervention group actively engage in weekly online psychoeducation sessions via Zoom and access the study website (www.onkodestek.org), while the control group receives standard care only. Both participants and researchers are aware of group allocation. The interactive nature of the psychoeducation program and direct participant-researcher contact during sessions make blinding impossible.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Two-arm parallel group randomized controlled trial comparing web-based psychoeducation program plus standard care versus standard care alone in breast cancer survivors.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Advanced Practice Nurse

Study Record Dates

First Submitted

December 1, 2025

First Posted

December 16, 2025

Study Start

May 1, 2025

Primary Completion

December 15, 2025

Study Completion

February 1, 2026

Last Updated

December 16, 2025

Record last verified: 2025-12

Locations